JBIO
Jade Biosciences, Inc.
Next earnings Aug 11, 2026 (before open) · consensus $-0.66 EPS
Last earnings -3.6% on 2026-05-07
$21.90
▼ -0.32%$21.90▲ +132.73%
over 1Y
L $6.77EODHDH $26.85
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-0.3%
1W+29.8%
1M+0.9%
3M+57.0%
YTD+54.7%
1Y+132.7%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 16 analysts
Strong Buy
Conservative balance sheet (liabilities/equity 0.05x).
Jade Biosciences, Inc. shows limited reported revenue, and -38.3% ROE.
Sources: SEC EDGAR (CIK 0001798749, latest 10-Q filed 2026-05-07) · EODHD · as of 6/25/2026, 10:18:39 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.